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Background
In 2004, the Korean government and blood transfusion community deliberated on the 
issue of a national blood system reform and agreed to implement a 5-year project (2004‒
2009) to further improve safety measures. Our study delineates the basis of the current 
national blood program and analyzes the performance of this 5-year project initiated by 
the Korean government.
Methods
A performance review of the 5-year project was conducted from May 2009 to February 
2010 using various approaches. Numerous data and documentation were collected from 
the Korean Red Cross and the Korean Centers for Disease Control and Prevention and 
reviewed by experts. Approximately 20 interviews with representatives of stakeholder 
groups were conducted to gather information, opinions, and perceptions. We conducted 
a nationwide field survey on a total of 144 blood donor centers. 
Results
Among the 5 major categories of the 5-year project, blood donor recruitment, laboratory 
testing, and product manufacturing were improved in terms of quality performance. 
Specifically, government’s financial support ensured that the infrastructure of blood do-
nor centers and blood laboratory centers improved. The pivotal role of the government 
contributed to improvements in the national blood program and enhanced national sur-
veillance for blood safety.
Conclusion
Korea has made a tremendous effort with positive outcomes to provide safety measures 
for blood products for transfusion in its citizens. In all areas of blood management, from 
blood donations to transfusions, continuous developments in monitoring safety stand-
ards and practices are paramount. 
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INTRODUCTION
The management and allocation strategies of national 
blood programs vary according to each country’s established 
practices [1, 2]. The ability to provide safe and secure blood 
supply is the cornerstone of transfusion medicine in the 
health care community. However, a tremendous challenge 
exists in the field of blood supply as the demands for blood 
products is rising as a result of increased individual access 
to health care services and life expectancy. Blood products 
are not synthetic products but rather a limited resource de-
pendent on donor availability, and have therefore become 
an expensive resource.
Since 1981, the Korean Red Cross (KRC) has been respon-
sible for establishing quality performance and executing 
guidelines for the national blood program. However, a 
20-year retrospective database study revealed isolated cases 
of transfusion-transmitted infections (TTI) by human im-
munodeficiency virus (HIV), hepatitis B virus, and hepatitis 
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C virus (HCV), causing a perception among the public of 
poor quality blood bank services in Korea. Due to public 
distrust, an urgent course of action was needed to restore 
public confidence in the national blood system. A special 
committee was formed in April 2004 to address the concerns 
of the citizens and health care community. The 11 committee 
members consisted of the Deputy Minister for Social Welfare, 
the chairman of the Korean Society of Blood Transfusion, 
5 experts from academic institutions, 2 government officials 
from the Ministry of Health and Welfare, an official from 
the Prime Minister’s Office, and the director of the KRC 
Blood Service Headquarters. In 2004, multiple committee 
hearings, small and large group conferences, and on-site 
inspections were conducted to gather data on day-to-day 
operations. Five sectors of concern, 1) blood donor recruit-
ment, 2) blood testing and manufacturing, 3) blood supply 
and use, 4) blood service expertise enhancement, and 5) 
government responsibility for the national blood program, 
were identified as being problematic in the national blood 
program, and plans to rectify these issues over the following 
5 years were announced in September 2004. Following this, 
the Korean blood transfusion community announced that 
they would initiate actions to further improve safety meas-
ures from 2004–2009.
Our study delineates the basis of the current national 
blood program and analyzes the data and results of the 5-year 
project by the Korean government to ensure safe and secure 
blood supply.
MATERIAL AND METHODS
Data collection and documentation review
A performance review of the National Blood Safety 
Improvement Project was conducted from May 2009 to 
February 2010. It was important that a comprehensive data 
collection approach, especially from KRC, be established ear-
ly in the project. After this project was approved by the 
KRC institutional review board, a total of 66 documents 
or data were requested and secured. Requested data were 
classified into 8 categories including improvement of blood 
donor center facilities, encouragement of registered blood 
donors, assurance of stable supply of single donor platelets, 
support of voluntary blood drive, improvement of blood 
laboratory facilities, development of blood information shar-
ing system, transportation of blood products, and innovation 
in the organizational structure of the KRC. A total of 20 
documents were provided by the division of human blood 
safety surveillance of the Korea Centers for Disease Control 
and Prevention (KCDC). Key documents reviewed included 
national blood collection and utilization surveys, look-back 
system in transfusion-transmitted infection, inspection re-
sults of blood establishments/blood collection centers, educa-
tional activities by the government, and research activities 
of the KCDC.
Stakeholder interviews
Interviews were conducted to gather information, opin-
ions, and perceptions. Our team conducted approximately 
20 interviews with representatives of the following stake-
holder groups: current and past KRC blood services head-
quarter representatives, government representatives, hospi-
tal decision-makers, transfusion specialists, non-profit blood 
donor organization representatives, and consumer (patient) 
group representatives. The overall objective of the interviews 
was to obtain information that would allow an assessment 
of the performance of the national blood program. 
Field survey on blood donor centers
We conducted a field survey on a total of 144 blood donor 
centers from all over the country between July 2009 and 
October 2009. The survey was conducted in close collabo-
ration with the KRC and Hanmaum blood center. A 2-person 
surveyor team visited each blood donor center with the 
same questionnaires. Major survey items were related to 
facility (e.g., location, area, parking space, and space composi-
tion of each function), management of human resources, 
equipment, and transportation method of blood products. 
RESULTS
Current status of the national blood program after the 5-year 
project
The Ministry of Health and Welfare is responsible for 
the national blood program in Korea (Fig. 1). With the ex-
ecution of the 5-year project, 2 departments dedicated to 
the national blood program were established in the Ministry 
of Health and Welfare and the KCDC. Specifically, the divi-
sion of human blood safety surveillance in the KCDC played 
a key role in the implementation of the 5-year project. The 
Korea Food and Drug Administration (KFDA) is responsible 
for regulating the plasma fractionation industry by licensing 
facilities and products, on-site inspecting licensed plasma 
fractionators, and issuing and enforcing safety rules. New 
regulations on organization and operations of the National 
Blood Advisory Committee have been enacted to strengthen 
these activities.
The KRC plays a pivotal role in blood collection in Korea, 
being involved in tasks such as the manufacturing, testing, 
and distribution of blood products. They operate through 
their blood service headquarters, 16 regional blood centers, 
3 blood laboratory centers, 1 plasma fractionation center, 
and 1 blood transfusion research institute. The 16 regional 
blood centers are located in 8 provinces with 119 blood 
donor centers. Two alternate blood collection sites in Korea 
include the hospital blood centers and the Hanmaum blood 
center, which are private organizations. The total number 
of donations in 2009 was 2,579,954, of which 2,471,880 
(95.8%) were donated through the KRC; blood donation 
through the Hanmaum blood center and hospital blood cen-
ters accounted for only 108,074 donations (4.2%). The pro-
portion of blood units collected at these latter 2 institutions 
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Fig. 1. Structure of the national blood program in Korea.
Fig. 2. The changes in the number 
of donations and donation rate.
Fig. 3. The changes in the number 
of presenting donors and deferred 
donors and the donor deferral rate 
in the past 27 years.
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Table 1. Achievements of the national blood safety improvement project.
Project Items
Blood safety Storage of donated blood samples for 10 years (2004)
Establishment of the BISS (2006)
Addition of an anti-HTLV Ab testing (2009)
Introduction of NAT-HIV and NAT-HCV (2005)
Change of HBsAg testing by CLIA from ELISA (2007) 
Generation of a research fund by the KCDC to increase blood safety
Collection facility Improvement of donor centers (newly open and remodeled)
Consolidation of laboratory center Consolidation of laboratory center from 7 centers to 3 sites 
Introduction of an automated system for infectious disease screening 
Disaster recovery center for blood information Establishment of disaster recovery center for blood information network
Blood surveillance system & hemovigilance Look-back testing for transfusion-transmitted infections
Inspection of blood collection center
Abbreviations: BISS, blood information sharing system; Anti-HTLV Ab, anti-human T-lymphotropic virus antibody; NAT-HIV, nucleic acid 
amplification test for human immunodeficiency virus; NAT-HCV, nucleic acid amplification test for hepatitis C virus; HBsAg, hepatitis B surface
antigen; CLIA, chemiluminescence immunoassay; ELISA, enzyme-linked immunosorbent assay; KCDC, Korea Centers for Disease Control and
Prevention.
Fig. 4. The shift in the number of donations from group donors to 
individual donors. 
Fig. 5. The location of the 3 blood laboratory centers.
comprised 3–5% of the total blood donated in Korea. The 
Korean population in 2009 was 48,747,000 people, and 53 
of every 1,000 individuals were blood donors (donation rate: 
5.3%) (Fig. 2). Because of increasingly stringent donor criteria 
for the prevention of possible transfusion-transmitted in-
fections, the deferral rate was 19.4% of all donation candi-
dates in 2009 (Fig. 3).
Major achievements of the National Blood Safety Improve-
ment Project
The proposal for the National Blood Safety Improvement 
Project was divided into 5 main components: blood donor 
recruitment, laboratory testing, product manufacturing, sup-
ply chain, and use of blood products. The major achievements 
of this commitment are summarized in Table 1. The financial 
support from the government totaled 101 million US dollars, 
and the annual blood program operation cost increased to 
approximately 200 million US dollars over the 5 years.
Establishment and remodeling of blood donor centers
Before the 5-year project, Korea obtained many of its 
blood products through group donations, usually from stu-
dents or the military. Many blood donor centers were set 
up in high-traffic areas to attract more donors, and measures 
were taken to facilitate the donation process. Among 127 
blood donor centers (119 at the KRC and 8 at the Hanmaum 
blood center), 58 blood donor centers were newly established 
or remodeled through governmental financial support. 
Through these efforts, the number of individual donations 
increased, reaching 62.9% of the total number of donations 
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Table 2. Summary of look-back system in transfusion-transmitted infections.
Phase Method Processing Inspection 
1st phase Medical information from patients transfused Review transfusion medical documents (e.g., 
blood no. date, components)
Test for infection marker results before transfusion 
Public health office at 
city or province 
hospital 
2nd phase Donation history from the donor using the 
BIMS 
Check the donor information 
Review donor medical treatment history 
KRC headquarters 
3rd phase Medical treatment history from national 
insurance data 
Retrieve data information system network with 
HIRA 
HIRA and/or hospital 
4th phase Retesting with sample stored at donation time Retest with stored sample at KRC KCDC → assigned Lab 
5th phase Retesting with new sample collected from 
donor 
Conduct appointment with donor and collect new 
blood sample 
KCDC → assigned 
collection services 
Abbreviations: KRC, Korean Red Cross; HIRA, Health Insurance Review and Assessment Service; KCDC, Korea Centers for Disease Control and
Prevention.
Table 3. Reported cases of transfusion-transmitted infections in 
Korea.
Year HIV HCV HBV Malaria HAV Total
1987–1996 10a) 0 0 0 0 10
1997   0 0 1 3 0 4
1998   0 0 0 4 0 4
1999   0 0 4 0 0 4
2000   0 4 2 2 0 8
2001   0 6 6 1 0 13
2002   4 4 0 0 0 8
2003   2 0 1 0 0 3
2004   0 1 0 0 0 1
2005   0 0 0 0 0 0
2006   0 0 0 1 0 1
2007   0 0 0 1 0 1
2008   0 0 0 1 1 2
2009   0 0 0 0 0 0
Total 16 15 14 13 1 59
a)HIV: 1 case, 1987; 1 case, 1988; 3 cases, 1989; 2 cases, 1991; 2 
cases, 1992; 1 case, 1993. 
Abbreviations: HIV, human immunodeficiency virus; HBV, 
hepatitis B virus; HCV, hepatitis C virus; HAV, hepatitis A virus.
in 2009 (Fig. 4).
Consolidation of blood laboratory centers
The blood laboratory centers that perform testing for in-
fectious disease markers were consolidated from 7 locations 
to 3 sites, located in Seoul (capital of Korea), Daejeon (center 
of the country), and Busan (southernmost large city in the 
country) (Fig. 5). The following screenings are performed 
in these laboratories: hepatitis B virus surface antigen (Ag) 
and anti-human T-lymphotropic virus antibody (Ab) by 
chemiluminescence immunoassay, anti-human HIV Ab and 
anti-HCV Ab by enzyme immunoassay, nucleic acid amplifi-
cation test (NAT) for HIV and HCV, serologic test for syphilis 
by Treponema pallidum particle agglutination assay, and 
alanine aminotransferase test by chemistry analyzer. For 
blood samples collected during the day, testing is performed 
the same evening in the laboratory.
Establishment of the Blood Information Sharing System
The Blood Information Sharing System (BISS) network 
between the KRC and hospital blood centers was completed 
in 2006 by the KRC. The objective of the system was to 
provide real-time information on the availability of specific 
blood products, especially when the hospital seeks a rare 
blood type. The system allows for immediate exchange of 
information from any location through mobile devices. 
Information regarding previous results of infectious disease 
markers of blood donors who donated at the KRC collection 
center since 1981 is recorded in the KRC Donor Registry 
database and available for real-time acquisition by the KRC 
blood donor centers and hospital blood centers. This process 
was completed in 2005, and a backup of the system at the 
national disaster control center was completed in 2009. In 
addition, the KRC receives donor information from the 
KCDC database for new enrollment of HIV-, malaria-, 
Brucella-, and Babesia-infected patients. Furthermore, in-
formation has been collected from the Health Insurance 
Review and Assessment Service (HIRA) and military services 
databases for data on growth hormone and hepatitis B im-
munoglobulin medications, as well as medications for bald-
ness, psoriasis, and prostate hypertrophy, among others, for 
screening after collection.
Look-back system in transfusion-transmitted infection 
In 2005, the KCDC initiated a retrospective analysis on 
blood that had been transfused and was under suspicion 
for causing infections. For suspected cases of TTI, the donor 
history was carefully inspected. Then, further evaluation 
assessing whether the donor made multiple donations at 
the suspected time was conducted. If these evaluations were 
negative, TTI was ruled out. Since 2005, all tested samples 
of donated blood have been stored in the KRC storage bank 
for a period of 10 years. Stored samples undergo repeated 
testing for infections; if these tests do not yield positive 
results, TTI is ruled out. If more information is required 
to confirm TTI, more data regarding the donor are confirmed 
using medical treatment histories from the health insurance 
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database using the national HIRA network. If TTI still cannot 
be ruled out, the donor is contacted and a new sample is 
collected. Table 2 summarizes the review and assessment 
process for TTI. Because data collection began in 2005, there 
are some gaps between the transfused and reported dates. 
As a result of this system, the number of reported cases 
of infection has decreased each year, and the number of 
TTIs involving diseases such as hepatitis B, hepatitis C, and 
HIV have not increased since 2005 (Table 3).
DISCUSSION
While the government oversees the national blood pro-
gram in Korea, the specifics of the blood collection, manu-
facturing of blood products, and testing of blood samples 
are overseen and executed by the KRC. The national blood 
program was consigned to the KRC in 1981, with the ex-
ception of a few private operations. However, the emergence 
of 6 cases of transfusion-induced AIDS in 2004 instigated 
safety concerns from the public [3]. This led to the opening 
of a private blood establishment, the Hanmaum blood center. 
Since then, blood products have been collected by 3 main 
organizations: the KRC, the Hanmaum blood center, and 
hospital blood centers.
The primary goal of the 5-year project was to restore 
public trust in blood donation and transfusion. In terms 
of blood donation, the total number of donations has been 
restored from 2,087,762 in 2007 to 2,575,954 in 2009. 
Furthermore, the proportion of individual donations in-
creased from 41.9% in 2003 to 62.5% in 2009. The establish-
ment of new blood donor centers and remodeling of existing 
blood donor centers through this 5-year project led to many 
dramatic changes in how blood donation is carried out in 
Korea. Improved services at blood donor centers including 
friendly staff and physical infrastructure, easy access and 
registration, and more comfortable space led to high donor 
satisfaction. Our field survey revealed higher scores for blood 
donor centers rebuilt by governmental financial support than 
for existing blood donor centers.
The second goal of the 5-year project was to ensure the 
safety of blood products and their transfusion. Numerous 
actions performed to ensure safety of blood products include 
consolidation of blood laboratory centers, implementation 
of laboratory automation systems in blood laboratory centers, 
implementation of NAT screening for HIV and HCV, im-
plementation of anti-HTLV Ab testing, and establishment 
of BISS for real-time acquisition of information. As a result 
of this project, there have been no newly documented cases 
of transfusion-transmitted HIV, HCV, or HBV infection. 
In conclusion, Korea has made a tremendous effort with 
positive results to offer safety measures for blood products 
for transfusions in its citizens. In all aspects, from blood 
donations to transfusions, continued developments in mon-
itoring safety standards and practices are paramount in each 
of the existing settings: the KRC and private blood establish-
ments (including hospital blood centers and the Hanmaum 
blood center). We hope that the government will continue 
their initiative to ensure safety in national blood supply 
and services.
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